- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02139683
Feasibility Study Assessing the Treatment of Fibroadenomata With a Circumferential Sonication Treatment With HIFU
May 25, 2018 updated by: Theraclion
High Intensity Focused Ultrasound for the Treatment of Fibroadenomata (HIFU-F)
The purpose of this study is to assess the treatment of fibroadenomata with a circumferential sonification treatment with HIFU..
Study Overview
Detailed Description
Primary endpoint: fibroadenomata size reduction post-treatment on ultrasound imaging.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
London, United Kingdom, SE1 9RT
- Kings College London, Guy's & St Thomas' Hospitals, Department of Research Oncology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients >18 years of age
- Fibroadenomata diagnosed according to local hospital protocol; ultrasound alone on patients <25 and ultrasound plus core-biopsy in patients >25 (Graded B2 or less)
- Visible on ultrasound (Graded U2/U3)
- Definitive diagnosis of fibroadenomata confirmed by the Breast multi-disciplinary team meeting (MDT).
Exclusion Criteria:
- Lesion with atypia or suspicion of phyllodes (Graded B3 or greater)
- Pregnant or lactating women
- History of laser or radiation therapy to the targeted breast
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: HIFU treatment
HIFU treatment in patient diagnosed with fibroadenoma
|
HIFU treatment in patients with fibroadenoma
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in size of fibroadenomata as recorded on ultrasound imaging
Time Frame: Month 1, Month 3, Month 12
|
Month 1, Month 3, Month 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost-effectiveness
Time Frame: 12 months
|
12 months
|
|
|
Adverse Events
Time Frame: Month 1, Month 3, Month 12
|
Month 1, Month 3, Month 12
|
|
|
Patient recorded outcomes measures
Time Frame: Month 1, Month 3, Month 12
|
Patient questionnaires and VAS scales
|
Month 1, Month 3, Month 12
|
|
Mean treatment time
Time Frame: Treatment visit date
|
Treatment visit date
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Douek, MD, King's College London
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2014
Primary Completion (ACTUAL)
January 1, 2016
Study Completion (ACTUAL)
January 1, 2016
Study Registration Dates
First Submitted
February 5, 2014
First Submitted That Met QC Criteria
May 13, 2014
First Posted (ESTIMATE)
May 15, 2014
Study Record Updates
Last Update Posted (ACTUAL)
May 30, 2018
Last Update Submitted That Met QC Criteria
May 25, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HIFU-F
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Fibroadenoma
-
TheraclionActive, not recruitingBreast FibroadenomaBulgaria
-
TheraclionCompleted
-
Second Affiliated Hospital, School of Medicine,...OmixScience InstituteCompletedBreast Cancer | Breast Fibroadenoma | Breast HypoplasiaChina
-
University of ChicagoGuerbetCompletedBreast Cancer | Breast Neoplasms | Breast Diseases | Breast FibroadenomaUnited States
-
Medipol UniversityCompletedBreast Cancer | Breast Neoplasms | Breast Diseases | Breast FibroadenomaTurkey
-
University Hospital TuebingenTheraclionCompletedBreast FibroadenomaGermany
-
TheraclionCompleted
-
David R. Brenin, MDTheraclion SAS, Paris, FranceCompletedBreast FibroadenomaUnited States
-
InSightecTerminatedBreast FibroadenomaUnited States, Japan
-
B.P. Koirala Institute of Health SciencesCompletedBreast Neoplasms | Breast Fibroadenoma | Breast Pain | Breast DiseaseNepal
Clinical Trials on HIFU treatment
-
Queen Mary Hospital, Hong KongUnknown
-
TheraclionCompletedNon-malignant Thyroid NoduleBulgaria
-
Queen Mary Hospital, Hong KongCompleted
-
Seoul National University HospitalJeysis MedicalNot yet recruiting
-
Philips HealthcareTerminatedUterine FibroidsUnited States, Korea, Republic of, Canada
-
Queen Mary Hospital, Hong KongNot yet recruitingHPV Disease | Cervical Intraepithelial Neoplasia Grade I
-
EDAP TMS S.A.RecruitingEndometriosis, RectumFrance
-
EDAP TMS S.A.CompletedBenign Prostatic HyperplasiaFrance
-
Philips HealthcareCompleted
-
Hospices Civils de LyonEDAP TMS S.A.Recruiting